Human halothane reduction in vitro by cytochrome P450 2A6 and 3A4: identification of low and high KM isoforms.
Publication
, Journal Article
Spracklin, DK; Kharasch, ED
Published in: Drug Metab Dispos
June 1998
Duke Scholars
Published In
Drug Metab Dispos
ISSN
0090-9556
Publication Date
June 1998
Volume
26
Issue
6
Start / End Page
605 / 607
Location
United States
Related Subject Headings
- Pharmacology & Pharmacy
- Oxidation-Reduction
- Mixed Function Oxygenases
- Microsomes, Liver
- Lung
- Isoenzymes
- In Vitro Techniques
- Humans
- Halothane
- Cytochrome P-450 Enzyme System
Citation
APA
Chicago
ICMJE
MLA
NLM
Spracklin, D. K., & Kharasch, E. D. (1998). Human halothane reduction in vitro by cytochrome P450 2A6 and 3A4: identification of low and high KM isoforms. Drug Metab Dispos, 26(6), 605–607.
Spracklin, D. K., and E. D. Kharasch. “Human halothane reduction in vitro by cytochrome P450 2A6 and 3A4: identification of low and high KM isoforms.” Drug Metab Dispos 26, no. 6 (June 1998): 605–7.
Spracklin DK, Kharasch ED. Human halothane reduction in vitro by cytochrome P450 2A6 and 3A4: identification of low and high KM isoforms. Drug Metab Dispos. 1998 Jun;26(6):605–7.
Spracklin, D. K., and E. D. Kharasch. “Human halothane reduction in vitro by cytochrome P450 2A6 and 3A4: identification of low and high KM isoforms.” Drug Metab Dispos, vol. 26, no. 6, June 1998, pp. 605–07.
Spracklin DK, Kharasch ED. Human halothane reduction in vitro by cytochrome P450 2A6 and 3A4: identification of low and high KM isoforms. Drug Metab Dispos. 1998 Jun;26(6):605–607.
Published In
Drug Metab Dispos
ISSN
0090-9556
Publication Date
June 1998
Volume
26
Issue
6
Start / End Page
605 / 607
Location
United States
Related Subject Headings
- Pharmacology & Pharmacy
- Oxidation-Reduction
- Mixed Function Oxygenases
- Microsomes, Liver
- Lung
- Isoenzymes
- In Vitro Techniques
- Humans
- Halothane
- Cytochrome P-450 Enzyme System